Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its ...

Buying $100 In GMED: If an investor had bought $100 of GMED stock 10 years ago, it would be worth $294.81 today based on a price of $75.50 for GMED at the time of writing.

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve ...

Learn more about whether Glaukos Corporation or Globus Medical, Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether Globus Medical, Inc. or iRhythm Technologies, Inc. is a better investment based on AAII's A+ ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, ...

Globus Medical (NYSE:GMED – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Globus Medical GMED has experienced strong upward momentum in the past year, with its shares rising 41.8%. This has far outpaced the industry’s 7.5% decline and the S&P 500 composite’s 8.8% growth.